C. Jara

发表

Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study

J. Brunet, A. Guerrero-Zotano, S. González, 2020, Scientific Reports.

Identification of candidate SNPs for drug induced toxicity from differentially expressed genes in associated tissues.

J. Lundeberg, H. Gréen, C. Rodríguez-Antona, 2012, Gene.

Hepatic acetylator phenotype in bladder cancer patients.

L. Fernandez, C. Jara, J. Ladero, 1985, Annals of clinical research.

Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.

A. Ruíz, A. Lluch, S. González, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant docetaxel for high-risk, node-negative breast cancer.

A. Ruíz, A. Lluch, J. Zaluski, 2010, The New England journal of medicine.

Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)

M. Hidalgo, R. Hitt, C. Jara, 2007 .

Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)

A. Guerrero-Zotano, R. Andrés, A. Llombart-Cussac, 2019, Scientific Reports.

SEOM Clinical Guideline for bone metastases from solid tumours (2016)

M. Martín, M. A. Seguí, C. Grávalos, 2016, Clinical and Translational Oncology.

Why Young Patients with Cancer Require Different Coping Tools

C. Calderón, C. Jara, P. Jiménez-Fonseca, 2017 .

Electronic health records and patient registries in medical oncology departments in Spain

N. Ribelles, C. Jara, J. Chacón, 2021, Clinical and Translational Oncology.

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

C. Jara, E. Ciruelos, J. Baena, 2015, Clinical and Translational Oncology.

An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer.

C. Jara, A. Segura, R. de las Peñas, 2005, Clinical nutrition.

SEOM clinical guideline for treatment of cancer pain (2017)

R. Peñas, C. Grávalos, C. Jara, 2017, Clinical and Translational Oncology.

Differences in coping strategies among young adults and the elderly with cancer

C. Calderón, C. Jara, P. Jiménez-Fonseca, 2019, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity

R. Milne, C. Rodríguez-Antona, J. García-Donas, 2011, The Pharmacogenomics Journal.

Hepatic acetylator polymorphism in breast cancer patients.

C. Jara, G. Pérez-Manga, J. Ladero, 1987, Oncology.

Polymorphic oxidation of debrisoquine in women with breast cancer.

A. Llerena, C. Jara, J. Benítez, 1991, Oncology.

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.

A. Ruíz, V. Guillem, N. Ribelles, 2007, The Lancet. Oncology.

Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients

G. Gervasini, C. Jara, J. A. Carrillo, 2017, British journal of clinical pharmacology.

Biopsychosocial and clinical characteristics in patients with resected breast and colon cancer at the beginning and end of adjuvant treatment

C. Calderón, C. Jara, P. Jiménez-Fonseca, 2019, BMC Cancer.

Macroscopic Extramedullary Hematopoiesis Resembling Hepatic Metastases in Prostate Cancer

Hern, J. García-Donas, C. Jara, 2015 .

Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy

A. González-Neira, G. Pita, H. Gréen, 2013, Journal of Medical Genetics.

Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.

E. Espinosa, J. Feliu, P. Garrido, 1997, Oncology.

Debrisoquin oxidation genotype and susceptibility to lung cancer

C. Jara, J. Benítez, J. Agúndez, 1994, Clinical pharmacology and therapeutics.

A phase I study of erlotinib, bevacizumab and gemcitabine in patients with advanced pancreatic cancer

M. Hidalgo, C. Grávalos, C. Jara, 2007 .

Emotional functioning to screen for psychological distress in breast and colorectal cancer patients prior to adjuvant treatment initiation.

T. Ramón Y Cajal, C. Calderón, C. Jara, 2019, European journal of cancer care.

GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID‐19 Pandemic in Spain

F. Rojo, A. Guerrero-Zotano, J. García-Saenz, 2020, The oncologist.

Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen

E. Espinosa, J. Feliu, P. Garrido, 1996, Cancer Chemotherapy and Pharmacology.

Regulatory Polymorphisms in β-Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy

M. Dolan, H. Gréen, E. Åvall-Lundqvist, 2012, Clinical Cancer Research.

Title: Regulatory polymorphisms in β -tubulin IIa are associated with paclitaxel-induced peripheral neuropathy

M. Dolan, H. Gréen, E. Åvall-Lundqvist, 2012 .

Regulatory Polymorphisms in b-Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy

M. Dolan, L. Inglada-Perez, H. Wheeler, 2012 .

Predictive Biomarkers and Personalized Medicine Regulatory Polymorphisms in b-Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy

M. Dolan, L. Inglada-Perez, H. Wheeler, 2012 .

Preventive treatments for breast cancer: recent developments

A. Ruíz, R. Andrés, A. Barnadas, 2014, Clinical and Translational Oncology.

Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study

A. Ruíz, A. Lluch, V. Guillem, 2015, PloS one.

Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study

A. Ruíz, A. Lluch, V. Guillem, 2014, British Journal of Cancer.

Evaluating the Applicability of Data-Driven Dietary Patterns to Independent Samples with a Focus on Measurement Tools for Pattern Similarity.

A. Ruíz, A. Lluch, V. Guillem, 2016, Journal of the Academy of Nutrition and Dietetics.

Pretreatment neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte, and neutrophil/monocyte ratios and outcome in elderly breast cancer patients

C. Jara, B. Losada, D. Malón, 2018, Clinical and Translational Oncology.

Polymorphic oxidation of debrisoquine in lung cancer patients.

A. Llerena, C. Jara, J. A. Carrillo, 1991, European journal of cancer.

Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study.

A. Tres, E. Alba, M. Martín, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.

E. Alba, M. Ramos, Miguel Martín, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retrorectal cystic hamartoma as benign cause of CA 19-9 elevation.

M. Urioste, J. García-Donas, C. Jara, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

R‐CHOP‐14 in patients with diffuse large B‐cell lymphoma younger than 70 years: a multicentre, prospective study

M. Provencio, C. Jara, M. Llanos, 2008, Hematological oncology.

Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study

A. Ruíz, S. González, R. Andrés, 2017, PloS one.

Psychometric properties of Liverpool Stoicism Scale (LSS) in a cohort of patients with resected cancer in adjuvant treatment

U. Lorenzo-Seva, C. Calderón, C. Jara, 2017 .

The mediating role of spirituality (meaning, peace, faith) between psychological distress and mental adjustment in cancer patients

U. Lorenzo-Seva, C. Calderón, C. Jara, 2017, Supportive Care in Cancer.

Knowledge of hereditary renal cancer syndromes: a pending issue for oncologists

J. García-Donas, C. Jara, S. Hernando, 2011, Anti-cancer drugs.

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study.

A. Lluch, S. González, R. Andrés, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Capecitabine (X) as single agent in elderly patients (p) with metastatic breast cancer (MBC)

L. Calvo, C. Jara, J. Chacón, 2005 .

Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study

A. Ruíz, A. Lluch, J. Vioque, 2019, Scientific Reports.

Validity and Reliability of the Decision Regret Scale in Cancer Patients Receiving Adjuvant Chemotherapy.

U. Lorenzo-Seva, T. Ramón Y Cajal, C. Calderón, 2019, Journal of pain and symptom management.

Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study

J. Brunet, A. Guerrero-Zotano, S. González, 2020, Scientific Reports.

Physical activity and breast cancer risk by pathological subtype.

A. Ruíz, A. Lluch, M. Pollán, 2017, Gynecologic oncology.

Psychometric properties of the Shared Decision-Making Questionnaire (SDM-Q-9) in oncology practice

U. Lorenzo-Seva, C. Calderón, C. Jara, 2018, International journal of clinical and health psychology : IJCHP.

Comparison of Coping, Psychological Distress, and Level of Functioning in Patients With Gastric and Colorectal Cancer Before Adjuvant Chemotherapy.

C. Calderón, C. Jara, P. Jiménez-Fonseca, 2018, Journal of pain and symptom management.

The relationship between physician and cancer patient when initiating adjuvant treatment and its association with sociodemographic and clinical variables

C. Calderón, C. Jara, P. Jiménez-Fonseca, 2018, Clinical and Translational Oncology.

Prospective analysis of psychological differences between adult and elderly cancer patients during postoperative adjuvant chemotherapy

C. Calderón, C. Jara, P. Jiménez-Fonseca, 2018, Clinical and Translational Oncology.

Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas

J. Feliu, C. Jara, E. Casado, 2006, Cancer Chemotherapy and Pharmacology.

The oncology day hospital in Spain: an updated analysis of Spanish Society of Medical Oncology (SEOM) looking forward

F. Ayala, C. Jara, J. A. Virizuela, 2017, Clinical and Translational Oncology.

This is the peer reviewed version of the following article: Evaluating the Applicability of Data-Driven Dietary Patterns to Independent Samples with a Focus on Measurement Tools for Pattern Similarity

A. Ruíz, A. Lluch, V. Guillem, 2019 .

Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.

A. Ruíz, A. Lluch, S. González, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of gemcitabine plus vinorelbine (VG) versus vinorelbine (V) in patients (pts) with metastatic breast cancer (MBC) previously treated with anthracyclines (A) and taxanes (T). Final results of GEICAM 2000-04 study.

E. Alba, L. Calvo, M. Muñoz, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

P1-14-03: AVALUZ Study: First Line with Bevacizumab in Combination with Paclitaxel (P) and Gemcitabine (G) in Patients with HER-2 Negative Recurrent or Metastatic BC: PFS Analysis.

C. Jara, E. Ciruelos, J. Baena, 2011 .